Candlestick Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-401,302
Closed -$36.5M 82
2024
Q4
$36.5M Buy
+401,302
New +$38.3M 0.84% 42
2024
Q1
Sell
-200,000
Closed -$15.9M 104
2023
Q4
$15.9M Sell
200,000
-800,000
-80% -$60.2M 0.34% 67
2023
Q3
$71.1M Sell
1,000,000
-400,000
-29% -$29.9M 1.98% 14
2023
Q2
$108M Buy
1,400,000
+515,000
+58% +$39.9M 2.51% 5
2023
Q1
$66.5M Sell
885,000
-155,000
-15% -$11.5M 1.68% 17
2022
Q4
$81.9M Sell
1,040,000
-360,000
-26% -$27M 3.29% 3
2022
Q3
$98.3M Buy
1,400,000
+725,000
+107% +$56.8M 3.57% 2
2022
Q2
$54.1M Buy
+675,000
New +$52.8M 1.38% 22
2021
Q4
Sell
-95,000
Closed -$7.18M 118
2021
Q3
$7.18M Buy
+95,000
New +$7.54M 0.14% 101
2021
Q2
Sell
-375,000
Closed -$29.6M 105
2021
Q1
$29.6M Buy
+375,000
New +$29.4M 0.65% 60
2020
Q3
Sell
-350,000
Closed -$25.6M 91
2020
Q2
$25.6M Sell
350,000
-415,000
-54% -$29.5M 0.93% 39
2020
Q1
$50.8M Buy
765,000
+634,773
+487% +$44.8M 2.14% 20
2019
Q4
$8.96M Buy
+130,227
New +$8.88M 0.47% 54

Other funds holding CL

Candlestick Capital Management's CL Position: Q1 2025 in Review

Candlestick Capital Management sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 401,302 shares — an estimated $36.5M sold.

Candlestick Capital Management first reported a position in CL in Q4 2019 and held it in 13 quarters. The position peaked at $108M in Q2 2023. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Candlestick Capital Management reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Candlestick Capital Management sold 401,302 Colgate-Palmolive shares in Q1 2025, an estimated $36.5M.
  • Candlestick Capital Management first reported a position in Colgate-Palmolive in Q4 2019 and held it in 13 quarters.
  • Candlestick Capital Management's Colgate-Palmolive position peaked at $108M in Q2 2023.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Candlestick Capital Management's 13F filing for Q1 2025, filed 15 May 2025.